Spinal implant manufacturer SeaSpine posted $47.5 million in second quarter revenue, a 66 percent increase year over year.
Spinal Tech
SI-Bone posted significant revenue growth in the second quarter of 2021 compared to the same period last year.
Aurora Spine received 510(k) approval from the FDA for its Dexa-C cervical interbody system, according to an Aug. 3 news release.
Zimmer Biomet posted $2 billion in net sales during the second quarter of 2021 and saw growth across its spine and orthopedic segments.
Orthofix's M6-C artificial disc is being evaluated for contiguous two-level symptomatic cervical radiculopathy, according to an Aug. 2 news release.
From SeaSpine's purchase of a highly touted imaging system to a multibillion dollar deal that bolstered Stryker's extremities portfolio, here are eight acquisitions of $100 million or more made in the last eight months:
The spine market continued to stabilize in the second quarter as NuVasive reported a 44.8 percent increase in second-quarter net sales compared to the same period last year.
NuVasive's Pulse platform for spine surgery received FDA 510(k) approval, and it is now available for sale.
Smith+Nephew posted growth in all segments of its orthopedics business in the second quarter.
Medical device company MirRus raised $65 million in a round of funding for its Rhenium-based spine devices and heart disease treatment development, the company said July 27.
